APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vaccines For Children

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vaccines For Children Industry Growth and Trends Forecast to 2032

Report ID 174044880119 December 2025109 pages

Choose your research edition.

Industry ResearchVaccines For Children Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccines For Children Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Vaccines For Children Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccines For Children Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccines For Children Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Vaccines For Children market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vaccines For Children is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vaccines For Children is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccines For Children is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vaccines For Children include GSK, CSL, Hissen, J&J(Crucell), Jintan, MedImmune LLC, Tiantan, Hualan and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vaccines For Children market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vaccines For Children market size, estimates, and forecasts are presented in terms of sales volume (K Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vaccines For Children market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vaccines For Children.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vaccines For Children market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vaccines For Children Market by Company

GSK

CSL

Hissen

J&J(Crucell)

Jintan

MedImmune LLC

Tiantan

Hualan

Pfizer

Kangtai

Merck

Sanofi

China National Biotec

Vaccines For Children Segment by Type

Recombinant Vaccines

Polysaccharide Vaccines

Viral Vaccines

Others

Vaccines For Children Segment by Application

Hospital

Clinic

Vaccines For Children Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines For Children market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccines For Children and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines For Children.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vaccines For Children manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vaccines For Children in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant Vaccines Table 2. Major Company of Polysaccharide Vaccines Table 3. Major Company of Viral Vaccines Table 4. Major Company of Others Table 5. Global Vaccines For Children Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 7. Global Vaccines For Children Sales Market Share in Volume by Type (2021-2026) Table 8. Global Vaccines For Children Sales by Type (2021-2026) & (US$ Million) Table 9. Global Vaccines For Children Sales Market Share in Value by Type (2021-2026) Table 10. Global Vaccines For Children Price by Type (2021-2026) & (US$/Dose) Table 11. Global Vaccines For Children Sales by Type (2027-2032) & (K Doses) Table 12. Global Vaccines For Children Sales Market Share in Volume by Type (2027-2032) Table 13. Global Vaccines For Children Sales by Type (2027-2032) & (US$ Million) Table 14. Global Vaccines For Children Sales Market Share in Value by Type (2027-2032) Table 15. Global Vaccines For Children Price by Type (2027-2032) & (US$/Dose) Table 16. North America Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 17. North America Vaccines For Children Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 19. Europe Vaccines For Children Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 21. Asia-Pacific Vaccines For Children Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 23. Latin America Vaccines For Children Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Vaccines For Children Sales by Type (2021-2026) & (K Doses) Table 25. Middle East and Africa Vaccines For Children Sales by Type (2021-2026) & (US$ Million) Table 26. Vaccines For Children Industry Trends Table 27. Vaccines For Children Industry Drivers Table 28. Vaccines For Children Industry Opportunities and Challenges Table 29. Vaccines For Children Industry Restraints Table 30. Global Vaccines For Children Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Vaccines For Children Revenue Market Share by Company (2021-2026) Table 32. Global Vaccines For Children Sales by Company (2021-2026) & (K Doses) Table 33. Global Vaccines For Children Sales Share by Company (2021-2026) Table 34. Global Vaccines For Children Market Price by Company (2021-2026) & (US$/Dose) Table 35. Global Vaccines For Children Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Vaccines For Children Major Company Production Sites and Headquarters Table 37. Global Vaccines For Children Company, Product Type & Application Table 38. Global Vaccines For Children Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Vaccines For Children by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Vaccines For Children Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Vaccines For Children Sales by Region (2021-2026) & (K Doses) Table 43. Global Vaccines For Children Sales Market Share in Volume by Region (2021-2026) Table 44. Global Vaccines For Children Sales by Region (2021-2026) & (US$ Million) Table 45. Global Vaccines For Children Sales Market Share in Value by Region (2021-2026) Table 46. Global Vaccines For Children Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 47. Global Vaccines For Children Sales by Region (2027-2032) & (K Doses) Table 48. Global Vaccines For Children Sales Market Share in Volume by Region (2027-2032) Table 49. Global Vaccines For Children Sales by Region (2027-2032) & (US$ Million) Table 50. Global Vaccines For Children Sales Market Share in Value by Region (2027-2032) Table 51. Global Vaccines For Children Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2027-2032) Table 52. Global Vaccines For Children Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 54. Global Vaccines For Children Sales Market Share in Volume by Application (2021-2026) Table 55. Global Vaccines For Children Sales by Application (2021-2026) & (US$ Million) Table 56. Global Vaccines For Children Sales Market Share in Value by Application (2021-2026) Table 57. Global Vaccines For Children Price by Application (2021-2026) & (US$/Dose) Table 58. Global Vaccines For Children Sales by Application (2027-2032) & (K Doses) Table 59. Global Vaccines For Children Sales Market Share in Volume by Application (2027-2032) Table 60. Global Vaccines For Children Sales by Application (2027-2032) & (US$ Million) Table 61. Global Vaccines For Children Sales Market Share in Value by Application (2027-2032) Table 62. Global Vaccines For Children Price by Application (2027-2032) & (US$/Dose) Table 63. North America Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 64. North America Vaccines For Children Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 66. Europe Vaccines For Children Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 68. Asia-Pacific Vaccines For Children Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 70. Latin America Vaccines For Children Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Vaccines For Children Sales by Application (2021-2026) & (K Doses) Table 72. Middle East and Africa Vaccines For Children Sales by Application (2021-2026) & (US$ Million) Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 76. GSK Vaccines For Children Product Portfolio Table 77. GSK Recent Development Table 78. CSL Company Information Table 79. CSL Business Overview Table 80. CSL Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 81. CSL Vaccines For Children Product Portfolio Table 82. CSL Recent Development Table 83. Hissen Company Information Table 84. Hissen Business Overview Table 85. Hissen Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 86. Hissen Vaccines For Children Product Portfolio Table 87. Hissen Recent Development Table 88. J&J(Crucell) Company Information Table 89. J&J(Crucell) Business Overview Table 90. J&J(Crucell) Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 91. J&J(Crucell) Vaccines For Children Product Portfolio Table 92. J&J(Crucell) Recent Development Table 93. Jintan Company Information Table 94. Jintan Business Overview Table 95. Jintan Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 96. Jintan Vaccines For Children Product Portfolio Table 97. Jintan Recent Development Table 98. MedImmune LLC Company Information Table 99. MedImmune LLC Business Overview Table 100. MedImmune LLC Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 101. MedImmune LLC Vaccines For Children Product Portfolio Table 102. MedImmune LLC Recent Development Table 103. Tiantan Company Information Table 104. Tiantan Business Overview Table 105. Tiantan Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 106. Tiantan Vaccines For Children Product Portfolio Table 107. Tiantan Recent Development Table 108. Hualan Company Information Table 109. Hualan Business Overview Table 110. Hualan Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 111. Hualan Vaccines For Children Product Portfolio Table 112. Hualan Recent Development Table 113. Pfizer Company Information Table 114. Pfizer Business Overview Table 115. Pfizer Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 116. Pfizer Vaccines For Children Product Portfolio Table 117. Pfizer Recent Development Table 118. Kangtai Company Information Table 119. Kangtai Business Overview Table 120. Kangtai Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 121. Kangtai Vaccines For Children Product Portfolio Table 122. Kangtai Recent Development Table 123. Merck Company Information Table 124. Merck Business Overview Table 125. Merck Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 126. Merck Vaccines For Children Product Portfolio Table 127. Merck Recent Development Table 128. Sanofi Company Information Table 129. Sanofi Business Overview Table 130. Sanofi Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 131. Sanofi Vaccines For Children Product Portfolio Table 132. Sanofi Recent Development Table 133. China National Biotec Company Information Table 134. China National Biotec Business Overview Table 135. China National Biotec Vaccines For Children Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 136. China National Biotec Vaccines For Children Product Portfolio Table 137. China National Biotec Recent Development Table 138. North America Vaccines For Children Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 139. North America Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 140. North America Vaccines For Children Sales Market Share by Country (2021-2026) Table 141. North America Vaccines For Children Sales Forecast by Country (2027-2032) & (K Doses) Table 142. North America Vaccines For Children Sales Market Share Forecast by Country (2027-2032) Table 143. North America Vaccines For Children Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Vaccines For Children Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Vaccines For Children Market Share by Country (2021-2026) Table 146. North America Vaccines For Children Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Vaccines For Children Market Share Forecast by Country (2027-2032) Table 148. Europe Vaccines For Children Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 149. Europe Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 150. Europe Vaccines For Children Sales Market Share by Country (2021-2026) Table 151. Europe Vaccines For Children Sales Forecast by Country (2027-2032) & (K Doses) Table 152. Europe Vaccines For Children Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Vaccines For Children Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Vaccines For Children Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Vaccines For Children Market Share by Country (2021-2026) Table 156. Europe Vaccines For Children Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Vaccines For Children Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Vaccines For Children Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 160. Asia-Pacific Vaccines For Children Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Vaccines For Children Sales Forecast by Country (2027-2032) & (K Doses) Table 162. Asia-Pacific Vaccines For Children Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Vaccines For Children Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Vaccines For Children Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Vaccines For Children Market Share by Country (2021-2026) Table 166. Asia-Pacific Vaccines For Children Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Vaccines For Children Market Share Forecast by Country (2027-2032) Table 168. Latin America Vaccines For Children Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 169. Latin America Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 170. Latin America Vaccines For Children Sales Market Share by Country (2021-2026) Table 171. Latin America Vaccines For Children Sales Forecast by Country (2027-2032) & (K Doses) Table 172. Latin America Vaccines For Children Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Vaccines For Children Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Vaccines For Children Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Vaccines For Children Market Share by Country (2021-2026) Table 176. Latin America Vaccines For Children Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Vaccines For Children Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Vaccines For Children Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Vaccines For Children Sales by Country (2021-2026) & (K Doses) Table 180. Middle East and Africa Vaccines For Children Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Vaccines For Children Sales Forecast by Country (2027-2032) & (K Doses) Table 182. Middle East and Africa Vaccines For Children Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Vaccines For Children Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Vaccines For Children Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Vaccines For Children Market Share by Country (2021-2026) Table 186. Middle East and Africa Vaccines For Children Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Vaccines For Children Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Vaccines For Children Distributors List Table 191. Vaccines For Children Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Vaccines For Children Image Figure 2. Global Vaccines For Children Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccines For Children Market Size (2021-2032) & (US$ Million) Figure 4. Global Vaccines For Children Sales (2021-2032) & (K Doses) Figure 5. Recombinant Vaccines Image Figure 6. Global Recombinant Vaccines Sales YoY Growth (2021-2032) & (K Doses) Figure 7. Polysaccharide Vaccines Image Figure 8. Global Polysaccharide Vaccines Sales YoY Growth (2021-2032) & (K Doses) Figure 9. Viral Vaccines Image Figure 10. Global Viral Vaccines Sales YoY Growth (2021-2032) & (K Doses) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Doses) Figure 13. Global Vaccines For Children Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Vaccines For Children Market Share by Type 2025 VS 2032 Figure 15. North America Vaccines For Children Sales Market Share in Volume by Type in 2025 Figure 16. North America Vaccines For Children Sales Market Share in Value by Type in 2025 Figure 17. Europe Vaccines For Children Sales Market Share in Volume by Type in 2025 Figure 18. Europe Vaccines For Children Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Vaccines For Children Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Vaccines For Children Sales Market Share in Value by Type in 2025 Figure 21. Latin America Vaccines For Children Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Vaccines For Children Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Vaccines For Children Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Vaccines For Children Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Vaccines For Children Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Doses) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Doses) Figure 31. Global Vaccines For Children Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Vaccines For Children Market Share by Application 2025 VS 2032 Figure 33. North America Vaccines For Children Sales Market Share in Volume by Application in 2025 Figure 34. North America Vaccines For Children Sales Market Share in Value by Application in 2025 Figure 35. Europe Vaccines For Children Sales Market Share in Volume by Application in 2025 Figure 36. Europe Vaccines For Children Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Vaccines For Children Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Vaccines For Children Sales Market Share in Value by Application in 2025 Figure 39. Latin America Vaccines For Children Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Vaccines For Children Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Vaccines For Children Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Vaccines For Children Sales Market Share in Value by Application in 2025 Figure 43. North America Vaccines For Children Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 44. North America Vaccines For Children Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Vaccines For Children Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Vaccines For Children Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Vaccines For Children Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 48. Europe Vaccines For Children Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Vaccines For Children Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Vaccines For Children Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Vaccines For Children Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 52. Asia-Pacific Vaccines For Children Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Vaccines For Children Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Vaccines For Children Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Vaccines For Children Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 56. Latin America Vaccines For Children Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Vaccines For Children Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Vaccines For Children Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Vaccines For Children Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 60. Middle East and Africa Vaccines For Children Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Vaccines For Children Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Vaccines For Children Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Vaccines For Children Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Vaccines For Children Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Polysaccharide Vaccines
  • Viral Vaccines
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • GSK
  • CSL
  • Hissen
  • J&J(Crucell)
  • Jintan
  • MedImmune LLC
  • Tiantan
  • Hualan
  • Pfizer
  • Kangtai
  • Merck
  • Sanofi
  • China National Biotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vaccines For Children Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vaccines For Children Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vaccines For Children Market by Type
  6. 1.3.1 Recombinant Vaccines
  7. 1.3.2 Polysaccharide Vaccines
  8. 1.3.3 Viral Vaccines
  9. 1.3.4 Others
  10. 1.4 Global Vaccines For Children Market Size by Type
  11. 1.4.1 Global Vaccines For Children Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Vaccines For Children Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Vaccines For Children Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Vaccines For Children Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Vaccines For Children Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Vaccines For Children Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Vaccines For Children Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Vaccines For Children Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vaccines For Children Industry Trends
  2. 2.2 Vaccines For Children Industry Drivers
  3. 2.3 Vaccines For Children Industry Opportunities and Challenges
  4. 2.4 Vaccines For Children Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vaccines For Children Revenue (2021-2026)
  2. 3.2 Global Top Players by Vaccines For Children Sales (2021-2026)
  3. 3.3 Global Top Players by Vaccines For Children Price (2021-2026)
  4. 3.4 Global Vaccines For Children Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vaccines For Children Major Company Production Sites & Headquarters
  6. 3.6 Global Vaccines For Children Company, Product Type & Application
  7. 3.7 Global Vaccines For Children Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vaccines For Children Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vaccines For Children Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vaccines For Children Tier 1, Tier 2, and Tier 3
4 Vaccines For Children Regional Status and Outlook
  1. 4.1 Global Vaccines For Children Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vaccines For Children Historic Market Size by Region
  3. 4.2.1 Global Vaccines For Children Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vaccines For Children Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vaccines For Children Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vaccines For Children Forecasted Market Size by Region
  7. 4.3.1 Global Vaccines For Children Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vaccines For Children Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vaccines For Children Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vaccines For Children by Application
  1. 5.1 Vaccines For Children Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Vaccines For Children Market Size by Application
  5. 5.2.1 Global Vaccines For Children Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Vaccines For Children Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Vaccines For Children Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Vaccines For Children Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Vaccines For Children Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Vaccines For Children Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Vaccines For Children Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Vaccines For Children Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Vaccines For Children Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 CSL
  8. 6.2.1 CSL Company Information
  9. 6.2.2 CSL Business Overview
  10. 6.2.3 CSL Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSL Vaccines For Children Product Portfolio
  12. 6.2.5 CSL Recent Developments
  13. 6.3 Hissen
  14. 6.3.1 Hissen Company Information
  15. 6.3.2 Hissen Business Overview
  16. 6.3.3 Hissen Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hissen Vaccines For Children Product Portfolio
  18. 6.3.5 Hissen Recent Developments
  19. 6.4 J&J(Crucell)
  20. 6.4.1 J&J(Crucell) Company Information
  21. 6.4.2 J&J(Crucell) Business Overview
  22. 6.4.3 J&J(Crucell) Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 J&J(Crucell) Vaccines For Children Product Portfolio
  24. 6.4.5 J&J(Crucell) Recent Developments
  25. 6.5 Jintan
  26. 6.5.1 Jintan Company Information
  27. 6.5.2 Jintan Business Overview
  28. 6.5.3 Jintan Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jintan Vaccines For Children Product Portfolio
  30. 6.5.5 Jintan Recent Developments
  31. 6.6 MedImmune LLC
  32. 6.6.1 MedImmune LLC Company Information
  33. 6.6.2 MedImmune LLC Business Overview
  34. 6.6.3 MedImmune LLC Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 MedImmune LLC Vaccines For Children Product Portfolio
  36. 6.6.5 MedImmune LLC Recent Developments
  37. 6.7 Tiantan
  38. 6.7.1 Tiantan Company Information
  39. 6.7.2 Tiantan Business Overview
  40. 6.7.3 Tiantan Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Tiantan Vaccines For Children Product Portfolio
  42. 6.7.5 Tiantan Recent Developments
  43. 6.8 Hualan
  44. 6.8.1 Hualan Company Information
  45. 6.8.2 Hualan Business Overview
  46. 6.8.3 Hualan Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hualan Vaccines For Children Product Portfolio
  48. 6.8.5 Hualan Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Vaccines For Children Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Kangtai
  56. 6.10.1 Kangtai Company Information
  57. 6.10.2 Kangtai Business Overview
  58. 6.10.3 Kangtai Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Kangtai Vaccines For Children Product Portfolio
  60. 6.10.5 Kangtai Recent Developments
  61. 6.11 Merck
  62. 6.11.1 Merck Company Information
  63. 6.11.2 Merck Business Overview
  64. 6.11.3 Merck Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Merck Vaccines For Children Product Portfolio
  66. 6.11.5 Merck Recent Developments
  67. 6.12 Sanofi
  68. 6.12.1 Sanofi Company Information
  69. 6.12.2 Sanofi Business Overview
  70. 6.12.3 Sanofi Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sanofi Vaccines For Children Product Portfolio
  72. 6.12.5 Sanofi Recent Developments
  73. 6.13 China National Biotec
  74. 6.13.1 China National Biotec Company Information
  75. 6.13.2 China National Biotec Business Overview
  76. 6.13.3 China National Biotec Vaccines For Children Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 China National Biotec Vaccines For Children Product Portfolio
  78. 6.13.5 China National Biotec Recent Developments
7 North America by Country
  1. 7.1 North America Vaccines For Children Sales by Country
  2. 7.1.1 North America Vaccines For Children Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vaccines For Children Sales by Country (2021-2026)
  4. 7.1.3 North America Vaccines For Children Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vaccines For Children Market Size by Country
  6. 7.2.1 North America Vaccines For Children Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vaccines For Children Market Size by Country (2021-2026)
  8. 7.2.3 North America Vaccines For Children Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vaccines For Children Sales by Country
  2. 8.1.1 Europe Vaccines For Children Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vaccines For Children Sales by Country (2021-2026)
  4. 8.1.3 Europe Vaccines For Children Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vaccines For Children Market Size by Country
  6. 8.2.1 Europe Vaccines For Children Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vaccines For Children Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vaccines For Children Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vaccines For Children Sales by Country
  2. 9.1.1 Asia-Pacific Vaccines For Children Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vaccines For Children Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vaccines For Children Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vaccines For Children Market Size by Country
  6. 9.2.1 Asia-Pacific Vaccines For Children Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vaccines For Children Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vaccines For Children Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vaccines For Children Sales by Country
  2. 10.1.1 South America Vaccines For Children Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vaccines For Children Sales by Country (2021-2026)
  4. 10.1.3 South America Vaccines For Children Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vaccines For Children Market Size by Country
  6. 10.2.1 South America Vaccines For Children Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vaccines For Children Market Size by Country (2021-2026)
  8. 10.2.3 South America Vaccines For Children Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vaccines For Children Sales by Country
  2. 11.1.1 Middle East and Africa Vaccines For Children Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vaccines For Children Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vaccines For Children Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vaccines For Children Market Size by Country
  6. 11.2.1 Middle East and Africa Vaccines For Children Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vaccines For Children Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vaccines For Children Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vaccines For Children Value Chain Analysis
  2. 12.1.1 Vaccines For Children Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vaccines For Children Production Mode & Process
  7. 12.2 Vaccines For Children Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vaccines For Children Distributors
  10. 12.2.3 Vaccines For Children Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst